| Title : Dual soluble epoxide hydrolase inhibitor - farnesoid X receptor agonist interventional treatment attenuates renal inflammation and fibrosis - Khan_2023_Front.Immunol_14_1269261 |
| Author(s) : Khan MAH , Nolan B , Stavniichuk A , Merk D , Imig JD |
| Ref : Front Immunol , 14 :1269261 , 2023 |
| Abstract : Khan_2023_Front.Immunol_14_1269261 |
| ESTHER : Khan_2023_Front.Immunol_14_1269261 |
| PubMedSearch : Khan_2023_Front.Immunol_14_1269261 |
| PubMedID: 38235144 |